• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

刺突蛋白与血管紧张素转换酶抑制剂以及来自具有生物学意义的化学实体的选定化合物之间的相互作用。

Interaction of spike protein with angiotensin converting enzyme inhibitors and selected compounds from the chemical entities of biological interest.

作者信息

Aminu Suleiman, Ibrahim Mohammed Auwal, Sallau Abdullahi Balarabe

机构信息

Department of Biochemistry, Ahmadu Bello University, Zaria, Nigeria.

出版信息

Beni Suef Univ J Basic Appl Sci. 2021;10(1):48. doi: 10.1186/s43088-021-00138-3. Epub 2021 Aug 25.

DOI:10.1186/s43088-021-00138-3
PMID:34458381
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8386153/
Abstract

BACKGROUND

Recent COVID-19 outbreak has prompted the search of novel therapeutic agents to treat the disease. The initial step of the infection involves the binding of the virus through the viral spike protein with the host angiotensin converting enzyme 2 (ACE2). In this study, the interaction of some ACE or ACE2 inhibitors and their analogues as well as selected compounds with the viral spike protein as a strategy to hinder viral-ACE2 interaction were investigated. spike protein as well as the ligands were retrieved from protein databank and ChEBI database respectively. The molecules were prepared before initiating the virtual screening using PyRx software. Discovery studio was used to further visualize the binding interactions between the compounds and the protein.

RESULTS

The ACE inhibitors and their analogues fosinopril (1-), fosinopril and moexipril have the best binding affinity to the protein with binding energies < - 7.0 kcal/mol while non-flavonoid stilben-4-ol binds with free binding energy of - 7.1 kcal/mol. Others compounds which belong to either the flavonoids, terpenes and alkaloid classes also have binding energies  < - 7.0 kcal/mol. Such high binding energies were enhanced via hydrogen bond (h-bond) interactions in addition to other interactions observed between the compounds and the amino acid residues of the protein.

CONCLUSIONS

The ACE inhibitors and their analogues as well as the selected compounds could serve as inhibitors of the spike protein as well as lead in drug discovery processes to target the virus.

摘要

背景

近期的新型冠状病毒肺炎(COVID-19)疫情促使人们寻找治疗该疾病的新型治疗药物。感染的初始步骤涉及病毒通过病毒刺突蛋白与宿主血管紧张素转换酶2(ACE2)结合。在本研究中,研究了一些ACE或ACE2抑制剂及其类似物以及选定化合物与病毒刺突蛋白的相互作用,以此作为阻碍病毒与ACE2相互作用的策略。刺突蛋白和配体分别从蛋白质数据库和ChEBI数据库中检索。在使用PyRx软件启动虚拟筛选之前,先对分子进行了制备。使用Discovery studio进一步可视化化合物与蛋白质之间的结合相互作用。

结果

ACE抑制剂及其类似物福辛普利(1-)、福辛普利和莫昔普利与该蛋白质具有最佳结合亲和力,结合能< -7.0 kcal/mol,而非黄酮类芪-4-醇的自由结合能为-7.1 kcal/mol。其他属于黄酮类、萜类和生物碱类的化合物的结合能也< -7.0 kcal/mol。除了观察到的化合物与蛋白质氨基酸残基之间的其他相互作用外,这种高结合能还通过氢键(h键)相互作用得到增强。

结论

ACE抑制剂及其类似物以及选定的化合物可作为刺突蛋白的抑制剂,并在针对该病毒的药物发现过程中发挥引领作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92b5/8386153/65836ea085fa/43088_2021_138_Fig1a_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92b5/8386153/65836ea085fa/43088_2021_138_Fig1a_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/92b5/8386153/65836ea085fa/43088_2021_138_Fig1a_HTML.jpg

相似文献

1
Interaction of spike protein with angiotensin converting enzyme inhibitors and selected compounds from the chemical entities of biological interest.刺突蛋白与血管紧张素转换酶抑制剂以及来自具有生物学意义的化学实体的选定化合物之间的相互作用。
Beni Suef Univ J Basic Appl Sci. 2021;10(1):48. doi: 10.1186/s43088-021-00138-3. Epub 2021 Aug 25.
2
Structure-based virtual screening and molecular docking of drugs against the SARS-CoV-2 spike protein-ACE2 receptor complex.基于结构的针对 SARS-CoV-2 刺突蛋白-ACE2 受体复合物的药物虚拟筛选和分子对接。
Pak J Pharm Sci. 2022 Nov;35(6):1531-1538.
3
COVID-19 liver and gastroenterology findings: An analysis of SARS-CoV-2 interactions with liver molecules.2019冠状病毒病的肝脏和胃肠病学表现:严重急性呼吸综合征冠状病毒2与肝脏分子相互作用的分析
World J Hepatol. 2022 Jun 27;14(6):1131-1141. doi: 10.4254/wjh.v14.i6.1131.
4
Molecular modeling of the interaction of ligands with ACE2-SARS-CoV-2 spike protein complex.配体与ACE2-SARS-CoV-2刺突蛋白复合物相互作用的分子模拟
In Silico Pharmacol. 2021 Oct 7;9(1):55. doi: 10.1007/s40203-021-00114-w. eCollection 2021.
5
Screening of inhibitors against SARS-CoV-2 spike protein and their capability to block the viral entry mechanism: A viroinformatics study.针对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)刺突蛋白的抑制剂筛选及其阻断病毒进入机制的能力:一项病毒信息学研究。
Saudi J Biol Sci. 2021 Jun;28(6):3262-3269. doi: 10.1016/j.sjbs.2021.02.066. Epub 2021 Feb 26.
6
Inhibitory mechanism of Ambroxol and Bromhexine Hydrochlorides as potent blockers of molecular interaction between SARS-CoV-2 spike protein and human angiotensin-converting Enzyme-2.氨溴索和盐酸溴己新作为 SARS-CoV-2 刺突蛋白与人血管紧张素转化酶 2 分子相互作用的有效阻滞剂的抑制机制。
J Mol Graph Model. 2022 Jul;114:108201. doi: 10.1016/j.jmgm.2022.108201. Epub 2022 Apr 21.
7
The interaction of the bioflavonoids with five SARS-CoV-2 proteins targets: An in silico study.生物类黄酮与五种 SARS-CoV-2 蛋白靶标的相互作用:一项计算机研究。
Comput Biol Med. 2021 Jul;134:104464. doi: 10.1016/j.compbiomed.2021.104464. Epub 2021 May 10.
8
Interactions of angiotensin-converting enzyme-2 (ACE2) and SARS-CoV-2 spike receptor-binding domain (RBD): a structural perspective.血管紧张素转化酶 2(ACE2)与严重急性呼吸系统综合征冠状病毒 2(SARS-CoV-2)刺突受体结合域(RBD)的相互作用:结构视角。
Mol Biol Rep. 2023 Mar;50(3):2713-2721. doi: 10.1007/s11033-022-08193-4. Epub 2022 Dec 23.
9
Different compounds against Angiotensin-Converting Enzyme 2 (ACE2) receptor potentially containing the infectivity of SARS-CoV-2: an in silico study.针对血管紧张素转化酶 2(ACE2)受体的不同化合物可能含有 SARS-CoV-2 的感染力:一项计算机研究。
J Mol Model. 2022 Mar 5;28(4):82. doi: 10.1007/s00894-022-05059-1.
10
Spike protein recognizer receptor ACE2 targeted identification of potential natural antiviral drug candidates against SARS-CoV-2.刺突蛋白识别受体 ACE2 靶向鉴定针对 SARS-CoV-2 的潜在天然抗病毒药物候选物。
Int J Biol Macromol. 2021 Nov 30;191:1114-1125. doi: 10.1016/j.ijbiomac.2021.09.146. Epub 2021 Sep 27.

引用本文的文献

1
An integrated approach based on FDA adverse event reporting system, network pharmacology, molecular docking, and molecular dynamics simulation analysis to study the cardiac adverse reactions and mechanism of action of osimertinib.基于美国食品药品监督管理局不良事件报告系统、网络药理学、分子对接和分子动力学模拟分析的综合方法,以研究奥希替尼的心脏不良反应及其作用机制。
Front Pharmacol. 2025 Jun 9;16:1619517. doi: 10.3389/fphar.2025.1619517. eCollection 2025.
2
Repurposed drugs in combinations exert additive anti-chikungunya virus activity: an in-vitro study.重新利用的药物组合具有相加的抗基孔肯雅病毒活性:一项体外研究。
Virol J. 2024 Jan 4;21(1):5. doi: 10.1186/s12985-023-02271-0.
3

本文引用的文献

1
Multidimensional in silico strategy for identification of natural polyphenols-based SARS-CoV-2 main protease (M) inhibitors to unveil a hope against COVID-19.多维计算机筛选策略鉴定天然多酚类化合物作为 SARS-CoV-2 主蛋白酶(Mpro)抑制剂,以期为抗击 COVID-19 带来新希望。
Comput Biol Med. 2022 Jun;145:105452. doi: 10.1016/j.compbiomed.2022.105452. Epub 2022 Mar 26.
2
identification and validation of natural antiviral compounds as potential inhibitors of SARS-CoV-2 methyltransferase.鉴定和验证天然抗病毒化合物作为 SARS-CoV-2 甲基转移酶潜在抑制剂的研究
J Biomol Struct Dyn. 2022 Sep;40(14):6534-6544. doi: 10.1080/07391102.2021.1886174. Epub 2021 Feb 15.
3
Molecular Docking and In-Silico Analysis of Natural Biomolecules against Dengue, Ebola, Zika, SARS-CoV-2 Variants of Concern and Monkeypox Virus.
针对登革热、埃博拉、寨卡、SARS-CoV-2 关切变异株和猴痘病毒的天然生物分子的分子对接和计算机分析。
Int J Mol Sci. 2022 Sep 22;23(19):11131. doi: 10.3390/ijms231911131.
4
Nanoscale Technologies in the Fight against COVID-19: From Innovative Nanomaterials to Computer-Aided Discovery of Potential Antiviral Plant-Derived Drugs.纳米技术在抗击 COVID-19 中的应用:从创新纳米材料到计算机辅助发现潜在的抗病毒植物衍生药物。
Biomolecules. 2022 Jul 30;12(8):1060. doi: 10.3390/biom12081060.
Structural basis of SARS-CoV-2 3CL and anti-COVID-19 drug discovery from medicinal plants.
严重急性呼吸综合征冠状病毒2 3CL的结构基础与药用植物抗新型冠状病毒药物发现
J Pharm Anal. 2020 Aug;10(4):313-319. doi: 10.1016/j.jpha.2020.03.009. Epub 2020 Mar 26.
4
The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro.美国食品药品监督管理局批准的药物伊维菌素可抑制 SARS-CoV-2 的体外复制。
Antiviral Res. 2020 Jun;178:104787. doi: 10.1016/j.antiviral.2020.104787. Epub 2020 Apr 3.
5
Coronavirus Disease 2019 (COVID-19): Do Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers Have a Biphasic Effect?2019冠状病毒病(COVID-19):血管紧张素转换酶抑制剂/血管紧张素受体阻滞剂是否具有双相效应?
J Am Heart Assoc. 2020 Apr 7;9(7):e016509. doi: 10.1161/JAHA.120.016509. Epub 2020 Apr 1.
6
Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV.SARS-CoV-2 刺突糖蛋白的特征及其对病毒进入的影响,以及与 SARS-CoV 的免疫交叉反应性。
Nat Commun. 2020 Mar 27;11(1):1620. doi: 10.1038/s41467-020-15562-9.
7
COVID-19, an emerging coronavirus infection: advances and prospects in designing and developing vaccines, immunotherapeutics, and therapeutics.COVID-19,一种新兴的冠状病毒感染:在疫苗、免疫疗法和治疗药物的设计和开发方面的进展和前景。
Hum Vaccin Immunother. 2020 Jun 2;16(6):1232-1238. doi: 10.1080/21645515.2020.1735227. Epub 2020 Mar 18.
8
Epidemiology, causes, clinical manifestation and diagnosis, prevention and control of coronavirus disease (COVID-19) during the early outbreak period: a scoping review.新型冠状病毒病(COVID-19)在早期暴发期间的流行病学、病因、临床表现和诊断、预防和控制:范围综述。
Infect Dis Poverty. 2020 Mar 17;9(1):29. doi: 10.1186/s40249-020-00646-x.
9
Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?高血压和糖尿病患者感染新型冠状病毒肺炎(COVID-19)的风险会增加吗?
Lancet Respir Med. 2020 Apr;8(4):e21. doi: 10.1016/S2213-2600(20)30116-8. Epub 2020 Mar 11.
10
COVID-19 spike-host cell receptor GRP78 binding site prediction.COVID-19 刺突-宿主细胞受体 GRP78 结合位点预测。
J Infect. 2020 May;80(5):554-562. doi: 10.1016/j.jinf.2020.02.026. Epub 2020 Mar 10.